The biotech company Colossal Biosciences has long aspired to bring back the extinct woolly mammoth, which roamed the Northern ...

Biotech company takes big step towards recreating woolly mammoth - Mice genes have been edited to give them woolly ...

Below is a summary of some of the measures identified in the Policy, and some suggestions for what foreign and domestic investors should ...

China announced a ban on Tuesday on imports of genetic sequencers from San Diego medical equipment maker Illumina, just ...

VIR's T-cell engagers have potential in oncology and showed promise with initial data in January 2025. Read my thoughts about ...

Colossal Biosciences announced Tuesday that it has simultaneously edited seven genes in mice embryos to create mice with long ...

Kinvard Bio has been formed through a licensing agreement with Harvard University. Kineticos is licensing research from the ...

23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...

The companies Eikon Therapeutics, Sionna Therapeutics, and Abcuro bagged the biggest biotech funding rounds overall in ...

Beijing imposed broad tariffs on imports of American food and said that 15 U.S. companies could no longer buy from China ...

Scientists at Colossal Biosciences have achieved a milestone to resurrecting the woolly mammoth: laboratory mice with thick, ...